Zynerba Pharmaceuticals, Inc. Annual Depreciation in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Zynerba Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2013 to 2022.
  • Zynerba Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2023 was $51.6K, a 14.9% decline year-over-year.
  • Zynerba Pharmaceuticals, Inc. annual Depreciation for 2022 was $219K, a 11.3% decline from 2021.
  • Zynerba Pharmaceuticals, Inc. annual Depreciation for 2021 was $247K, a 19.4% increase from 2020.
  • Zynerba Pharmaceuticals, Inc. annual Depreciation for 2020 was $207K, a 54.6% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $219K -$27.9K -11.3% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 $247K +$40.1K +19.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $207K +$73.2K +54.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-28
2019 $134K +$34.3K +34.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $99.6K +$5.36K +5.69% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-10
2017 $94.2K +$18.9K +25.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
2016 $75.3K +$49.3K +189% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-11
2015 $26K -$1.04K -3.83% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $27.1K -$22.3K -45.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-27
2013 $49.4K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.